A detailed history of Notis Mc Conarty Edward transactions in Novo Nordisk A S stock. As of the latest transaction made, Notis Mc Conarty Edward holds 2,600 shares of NVO stock, worth $351,572. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,600
Previous 3,000 13.33%
Holding current value
$351,572
Previous $385,000 3.64%
% of portfolio
0.15%
Previous 0.15%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $49,084 - $58,764
-400 Reduced 13.33%
2,600 $371,000
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $32,675 - $43,494
-320 Reduced 9.64%
3,000 $385,000
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $15,800 - $18,981
-180 Reduced 5.14%
3,320 $343,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $145,504 - $319,264
1,600 Added 84.21%
3,500 $318,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $15,597 - $17,265
-100 Reduced 5.0%
1,900 $307,000
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $20,510 - $27,066
-200 Reduced 9.09%
2,000 $270,000
Q2 2022

Jul 19, 2022

SELL
$103.24 - $121.81 $20,648 - $24,362
-200 Reduced 8.33%
2,200 $245,000
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $9,588 - $11,708
-100 Reduced 4.0%
2,400 $269,000
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $211,050 - $266,550
2,500 New
2,500 $240,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Notis Mc Conarty Edward Portfolio

Follow Notis Mc Conarty Edward and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.